Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study



Kamali H1 ; Hosseini S2 ; Aliabadi HR3 ; Poursadeghfard M4 ; Sahraian MA5 ; Eskandarieh S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neurology Research Center, Kerman University of Medical sciences, Kerman, Iran
  2. 2. Neurosciences Research Center, Tabriz University of Medical sciences, Tabriz, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Public Health Published:2022

Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Evidence of an Increased Prevalence of Multiple Sclerosis: A Population-Based Study of Tehran Registry During 1999-2018, BMC Neurology (2020)
2. Age and Sex Adjusted Prevalence and Annual Incidence of Multiple Sclerosis in East-Azerbaijan, Iran, Multiple Sclerosis and Related Disorders (2021)
3. Multiple Sclerosis Projection in Tehran, Iran Using Bayesian Structural Time Series, BMC Neurology (2021)
4. Evaluating the Efficacy and Safety of Zytuxtm (Rituximab, Aryogen Pharmed) in Iranian Multiple Sclerosis Patients: An Observational Study, Multiple Sclerosis and Related Disorders (2019)
5. The Correlation Between Dyslipidemia and Cognitive Impairment in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2019)
6. Prevalence of Multiple Sclerosis and Its Clinical and Demographic Characteristics in Kurdish Populations in Western Iran (2020), Multiple Sclerosis and Related Disorders (2022)
7. Pediatric Multiple Sclerosis and Its Familial Recurrence: A Population Based Study (1999–2017), Multiple Sclerosis and Related Disorders (2019)
8. Medical History Risk Factors in Primary Progressive Multiple Sclerosis: A Case-Control Study, Current Journal of Neurology (2021)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (17)
Sharareh Eskandarieh (12)
Other Related Docs
9. The Prevalence, Incidence and Familial Recurrence of Multiple Sclerosis in Tehran, Iran, Multiple Sclerosis and Related Disorders (2018)
10. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
11. Environmental Risk Factors of Multiple Sclerosis in the Middle East and North Africa Region: A Systematic Review, Current Journal of Neurology (2021)
12. Neuromyelitis Optica Spectrum Disorders in Iran, Multiple Sclerosis and Related Disorders (2017)
13. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
14. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
15. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
16. Determining the Effect of Sun Exposure and Physical Activity on the Incidence of Primary Progressive Multiple Sclerosis, Tehran University Medical Journal (2022)
17. Epidemiological Parameters of Multiple Sclerosis in Chaharmahal and Bakhtiari Province, Iran, Current Journal of Neurology (2023)
18. Epidemiology of Familial Multiple Sclerosis: A Population-Based Study in Tehran During 1999–2018, Multiple Sclerosis and Related Disorders (2020)
19. The Epidemiologic Trend of Multiple Sclerosis in Razavi Khorasan Province, Iran in Fifteen-Year Period, Multiple Sclerosis and Related Disorders (2025)
20. Prevalence and Incidence of Multiple Sclerosis in Ardabil, Northwest of Iran, Multiple Sclerosis and Related Disorders (2021)
21. Cladribine Tablets Are a Cost-Effective Strategy in High-Disease Activity Relapsing Multiple Sclerosis Patients in Iran, Current Journal of Neurology (2021)